Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
This is unchanged from the number of companies cited in the previous year.
Of the 26 citations issued, the most common citation was 'You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods'.
Most of the companies cited were involved in the Food and Cosmetics sector.
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Ameri-Kal, LLC | Food and Cosmetics | 09/12/2023 | Component - verify identity, dietary ingredient |
Ameri-Kal, LLC | Food and Cosmetics | 09/12/2023 | Quality control operations - finished batch, specifications |
Ameri-Kal, LLC | Food and Cosmetics | 09/12/2023 | Corrective action plans |
Ameri-Kal, LLC | Food and Cosmetics | 09/12/2023 | Tests, examinations - scientifically valid |
BTI Filtration | Devices | 05/11/2023 | Purchasing controls, Lack of or inadequate procedures |
BTI Filtration | Devices | 05/11/2023 | Lack of or inadequate receiving acceptance procedures |
Immuno-Mycologics, Inc. | Devices | 07/14/2023 | Evaluation of suppliers, contractors, etc., requirements |
Immuno-Mycologics, Inc. | Devices | 07/14/2023 | Lack of or inadequate process validation |
Kathleen N. Moore, M.D. | Drugs | 03/17/2023 | FD-1572, protocol compliance |
Quality Supplement Manufacturing, Inc. | Food and Cosmetics | 10/18/2023 | Quality control - reject; specification not met |
Quality Supplement Manufacturing, Inc. | Food and Cosmetics | 10/18/2023 | Criteria for establishing specifications |
Quality Supplement Manufacturing, Inc. | Food and Cosmetics | 10/18/2023 | Tests, examinations - scientifically valid |
Quality Supplement Manufacturing, Inc. | Food and Cosmetics | 05/04/2023 | Personnel - education, training, experience |
Quality Supplement Manufacturing, Inc. | Food and Cosmetics | 05/04/2023 | Specifications - identity, purity, strength, composition |
Quality Supplement Manufacturing, Inc. | Food and Cosmetics | 05/04/2023 | Specifications not met - reject, quality control |
Quality Supplement Manufacturing, Inc. | Food and Cosmetics | 05/04/2023 | Material review, disposition, follow-up; identification |
Quality Supplement Manufacturing, Inc. | Food and Cosmetics | 05/04/2023 | Master manufacturing record - sampling, tests, examinations |
Quality Supplement Manufacturing, Inc. | Food and Cosmetics | 05/04/2023 | Batch record - follow master |
Quality Supplement Manufacturing, Inc. | Food and Cosmetics | 05/04/2023 | Batch record - manufacture |
Quality Supplement Manufacturing, Inc. | Food and Cosmetics | 05/04/2023 | Batch record - reprocessing |
Quality Supplement Manufacturing, Inc. | Food and Cosmetics | 05/04/2023 | Tests, examinations - scientifically valid |
Route 66 Provisions, L.L.C. | Food and Cosmetics | 09/19/2023 | Pest control |
Seeds N Snacks, LLC. | Food and Cosmetics | 07/12/2023 | Develop FSVP |
Steven Sarkisian, M.D. | Drugs | 08/04/2023 | FD-1572, protocol compliance |
TVT Sharetea, LLC | Food and Cosmetics | 07/13/2023 | Develop FSVP |
US Foods | Food and Cosmetics | 02/03/2023 | Food safety hazards |